Citation Results

Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?

Stefan Sleijfer & Gerrit Stoter

Nature Reviews Clinical Oncology 2, 70 - 71 (2005) | doi:10.1038/ncponc0076.

Full Text